Tiny muscle biopsies could unlock secrets of cancer wasting
NCT ID NCT06780423
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at muscle structure in colorectal cancer patients who experience cachexia—severe weight and muscle loss. Researchers will take small muscle samples from the back and thigh, along with blood tests and scans, to compare muscle health between cachectic patients, non-cachectic patients, and healthy volunteers. The goal is to better understand why muscle wasting happens, which may guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help researchers better understand muscle wasting in cancer, potentially pointing toward future treatments or supportive care strategies.
- What could go wrong
- This is a small, early observational study with only 60 participants. It does not test any treatment, so it may not directly lead to new therapies or change patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER CACHEXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hasselt University - REVAL research institution
RECRUITINGDiepenbeek, Limburg, 3520, Belgium
-
Jessa Hospital
RECRUITINGHasselt, Limburg, 3500, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?